COMMUNIQUÉS West-GlobeNewswire

Hemispherx Announces Pricing of $2.57 Million Registered Direct Offering at a Premium to Market

20/04/2018 - 15:28

ORLANDO, Fla., April 20, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American:HEB) (“Hemispherx” or the “Company”), a research and development and emerging commercial growth company focused on unmet [...]

Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States

20/04/2018 - 15:24

Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO ® (fosnetupitant/ palonosetron) in the United States Lugano, Switzerland April 20, 2018 - Helsinn, a Swiss pharmaceutical group focused on [...]

Ceapro Inc. Reports 2017 Financial Results

20/04/2018 - 15:00

Year marked by increased investments in product pipeline and enabling technologies EDMONTON, Alberta, April 20, 2018 (GLOBE NEWSWIRE) -- Ceapro Inc. (TSX-V: CZO ) (“Ceapro” or the “Company”) , a growth-stage [...]

ATW Tech Announces Completion of Einsteinium Cryptocurrency Integration Phase I

20/04/2018 - 15:00

MONTREAL, April 20, 2018 (GLOBE NEWSWIRE) -- ATW Tech (“AtmanCo” or the “Company”) (TSX VENTURE:ATW) is proud to announce, as part of its ongoing global partnership with the Einsteinium Foundation ( “ EMC 2 ” ) (refer [...]

ATW Tech annonce la fin de la phase I de l’intégration de la crypto-monnaie Einsteinium sur sa plateforme de paiement unifiée

20/04/2018 - 15:00

MONTRÉAL, 20 avr. 2018 (GLOBE NEWSWIRE) -- ATW Tech (« AtmanCo Inc. » ou la « Société ») (TSX CROISSANCE:ATW) est fière d'annoncer que, dans le cadre de son partenariat mondial avec la Fondation Einsteinium (« EMC 2 ») [...]

Diversicare to Announce First Quarter 2018 Financial Results on Thursday, May 3, 2018

20/04/2018 - 15:00

BRENTWOOD, Tenn., April 20, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ) today announced that it is scheduled to report financial results for its first quarter ended March 31, 2018, on [...]

NewLink Genetics to Host Its First Quarter 2018 Financial Results Conference Call on May 3, 2018

20/04/2018 - 15:00

AMES, Iowa, April 20, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced that it will release its first quarter 2018 financial results on Thursday, May 3, 2018. The company has [...]

SELLAS Life Sciences Announces Appointment of Gene Mack as Chief Financial Officer & Treasurer

20/04/2018 - 14:45

NEW YORK, April 20, 2018 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group Inc., (Nasdaq: SLS ) (SELLAS), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies for a broad range of cancer [...]

Abeona Therapeutics Receives Orphan Drug Designation in the European Union for ABO-202 Gene Therapy Program in Batten Disease

20/04/2018 - 14:15

NEW YORK and CLEVELAND, April 20, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

Collegium to Host Conference Call to Discuss First Quarter 2018 Financial Results and Provide Corporate Update

20/04/2018 - 14:01

CANTON, Mass., April 20, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) announced today that the Company will host a conference call and live audio webcast on Wednesday, May 9, 2018 at 4:30 p.m [...]

Data from Multiple Celldex Programs Presented at American Association for Cancer Research (AACR) Annual Meeting 2018

20/04/2018 - 14:01

-- Early data from investigator-initiated pilot study of CDX-301/radiation therapy combination in patients with advanced NSCLC show promising effect on tumor burden even in non-irradiated tumors -- -- Additional four [...]

CareDx to Announce First Quarter 2018 Financial Results on May 10, 2018

20/04/2018 - 14:00

BRISBANE, Calif., April 20, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA ), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]

Arcturus Therapeutics Files Lawsuit Against Joseph E. Payne and His Associates for Violations of Federal Securities Laws

20/04/2018 - 14:00

Complaint Details Multiple Violations of Federal Securities Laws by Undisclosed Group Led by Payne SAN DIEGO, April 20, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines [...]

National Volunteer Week: Project HOPE Honors Unsung Heroes of Quest to Promote Global Health

20/04/2018 - 14:00

Nurse Jahn Moeller Named Volunteer of the Year Millwood, VA, April 20, 2018 (GLOBE NEWSWIRE) -- Volunteers are often the unsung heroes of the quest to promote global health and respond to disasters, but without their [...]

Taconic Biosciences Licenses Easi-CRISPR Technology from the University of Nebraska

20/04/2018 - 14:00

RENSSELAER, N.Y., April 20, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered mouse model and service solutions, has been granted a license to the Easi-CRISPR technology [...]

Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 AAN Conference

20/04/2018 - 13:01

Summit Therapeutics plc ('Summit', or 'the Company') Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual Meeting Data show correlation between decrease in muscle [...]

Cynata Therapeutics Completes Patent Application to Cover Cymerus™ Stem Cell Technology in the Treatment of Side Effects Related to CAR-T Therapy

20/04/2018 - 13:00

Initial data from preclinical study at the University of Massachusetts Amherst demonstrate Cymerus MSCs ameliorate the effects of cytokine release syndrome (CRS) and other related adverse reactions to CAR-T therapy [...]

Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 American Academy of Neurology Annual Meeting

20/04/2018 - 13:00

Data show correlation between decreases in muscle damage and reduction in muscle inflammation in patients treated with ezutromid OXFORD, United Kingdom and CAMBRIDGE, Mass., April 20, 2018 (GLOBE NEWSWIRE) -- Summit [...]

Emerald Health Therapeutics Names DDB Canada Agency of Record

20/04/2018 - 13:00

Powerful partnership will create globally-recognized brands that deliver trust and confidence to responsible cannabis users VICTORIA, British Columbia, April 20, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics Inc [...]